Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
128 studies found for:    "DMD-associated dilated cardiomyopathy" OR "Cardiomyopathy, Dilated"
Show Display Options
Rank Status Study
1 Suspended Autologous Stem Cells in Pediatric Patients With Dilated Cardiomyopathy
Condition: Cardiomyopathy, Dilated
Intervention: Procedure: Intracoronary autologous stem cell infusion
2 Terminated Cell Therapy in Dilated Cardiomyopathy: Observational Study
Condition: Cardiomyopathy, Dilated
Intervention: Other: Cell therapy
3 Recruiting Registry of Cell Therapy in Non-Ischemic Dilated Cardiomyopathy
Condition: Cardiomyopathy, Dilated
Intervention: Biological: Autologous stem cell therapy
4 Terminated
Has Results
Immunoadsorption Therapy for Patients With Non-Ischemic Dilated Cardiomyopathy (DCM)
Condition: Cardiomyopathy, Dilated
Intervention: Device: Mysorba
5 Recruiting Prognostic Value of Myocardial Fibrosis Quantified Using CMR in Patient With Dilated Cardiomyopathy
Condition: Cardiomyopathy, Dilated
Intervention: Other: CMR using T1 mapping technique
6 Completed Supramaximal Titrated Inhibition of RAAS in Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy
Interventions: Drug: Benazepril;   Drug: Valsartan;   Drug: Metoprolol
7 Recruiting A Clinical Study of Immunoadsorption Therapy for Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy
Intervention: Procedure: protein A immunoadsorption
8 Completed Nesiritide - Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy
Interventions: Drug: Nesiritide;   Drug: 5% Dextrose
9 Recruiting Multicenter Study of Immunoadsorption in Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy
Interventions: Device: protein A immunoadsorption;   Device: pseudo-immunoadsorption
10 Unknown  Cell Therapy In Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy
Intervention: Procedure: Stem cell
11 Completed
Has Results
Safety and Efficacy Study of Stem Cell Transplantation to Treat Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy
Interventions: Biological: CD34+ autologous stem cell transplantation;   Drug: Bone Marrow Stimulation;   Biological: SC therapy
12 Completed
Has Results
Coenzyme Q10 Supplementation in Children With Idiopathic Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy
Interventions: Drug: Coenzyme Q10;   Drug: Placebo
13 Terminated Defining the Role of Insulin Resistance in 'Idiopathic' Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy
Intervention: Drug: Rosiglitazone therapy
14 Unknown  Pathophysiology of Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy
Intervention:
15 Unknown  Intramuscular Injection of Mesenchymal Stem Cell for Treatment of Children With Idiopathic Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy
Intervention: Biological: umbilical cord mesenchymal stem cells
16 Completed Intracoronary Infusion of Autologous Bone Marrow Cells for Treatment of Idiopathic Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy
Intervention: Procedure: Intracoronary infusion of autologous bone marrow cells
17 Terminated PREclinical Mutation CARriers From Families With DIlated Cardiomyopathy and ACE Inhibitors
Condition: Dilated Cardiomyopathy
Interventions: Drug: perindopril;   Drug: placebo
18 Completed Bone Marrow Derived Adult Stem Cells for Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy
Interventions: Drug: granulocyte colony stimulating factor (GCSF);   Procedure: bone marrow mononuclear cells
19 Completed Use of Ixmyelocel-T (Formerly Cardiac Repair Cell [CRC] Treatment) in Patients With Heart Failure Due to Dilated Cardiomyopathy (IMPACT-DCM)
Condition: Dilated Cardiomyopathy
Interventions: Biological: Ixmyelocel-T;   Other: Standard of Care
20 Completed Use of Ixmyelocel-T (Formerly Catheter-based Cardiac Repair Cell [CRC]) Treatment in Patients With Heart Failure Due to Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy
Interventions: Biological: Ixmyelocel-T;   Other: Standard of Care

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.